206results about How to "Improve accuracy and precision" patented technology

The present invention relates to novel nasal pulse oximeter probes that are configured to be placed across the septum of the nose. These probes are fabricated to provide signals to obtain arterial oxygen saturation and other photoplethysmographic data. The present invention also relates to a combined nasal pulse oximeter probe/nasal cannula. The present invention also relates to other devices that combine a pulse oximeter probe with a device supplying oxygen or other oxygen-containing gas to a person in need thereof, and to sampling means for exhaled carbon dioxide in combination with the novel nasal probe. In certain embodiments, an additional limitation of a control means to adjust the flow rate of such gas is provided, where such control is directed by the blood oxygen saturation data obtained from the pulse oximeter probe.

Methods and system for noninvasive determination of tissue analytes utilize tissue properties as reflected in key features of an analytical signal to improve measurement accuracy and precision. Physiological conditions such as changes in water distribution among tissue compartments lead to complex alterations in the measured analytical signal of skin, leading to a biased noninvasive analyte measurement. Changes in the tissue properties are detected by identifying key features in the analytical signal responsive to physiological variations. Conditions not conducive to the noninvasive measurement are detected. Noninvasive measurements that are biased by physiological changes in tissue are compensated. In an alternate embodiment, the analyte is measured indirectly based on natural physiological response of tissue to changes in analyte concentration. A system capable of such measurements is provided.

The present invention relates to a novel non-invasive perfusion/resistance status monitor system and methods of using the same, and more specifically, a vascular perfusion status monitor system receiving and processing signals from at least two pulse oximeter probes, where each of the at least two pulse oximeter probes are situated at advantageously different locations in a patient. Novel pulse oximeter probes are configured to be placed, respectively, across the lip or cheek, across the septum or nares of the nose, and on the tongue. These probes are fabricated to provide signals to estimate arterial oxygen saturation. Conventional oximeter probes also can be configured to function according to the novel methods of determining differences in peripheral blood flow and/or resistance described herein.

The presence of a select analyte in the sample is evaluated in an an electrochemical system using a conduction cell-type apparatus. A potential or current is generated between the two electrodes of the cell sufficient to bring about oxidation or reduction of the analyte or of a mediator in an analyte-detection redox system, thereby forming a chemical potential gradient of the analyte or mediator between the two electrodes After the gradient is established, the applied potential or current is discontinued and an analyte-independent signal is obtained from the relaxation of the chemical potential gradient. The analyte-independent signal is used to correct the analyte-dependent signal obtained during application of the potential or current. This correction allows an improved measurement of analyte concentration because it corrects for device-specific and test specific factors such as transport (mobility) of analyte and/or mediator, effective electrode area, and electrode spacing (and as a result, sample volume), without need for separate calibration values. The analysis can be performed using disposable test strips in a hand held meter, for example for glucose testing.

A flexible touch screen panel includes a thin film substrate divided into an active area and a non active area positioned at the outside of the active area; sensing patterns formed on the active area of a first surface of the thin film substrate, including first sensing cells formed to be connected along a first direction and second sensing cells formed to be connected along a second direction; and sensing lines formed on the non active area of the first surface of the thin film substrate. The sensing lines are connected to the sensing patterns. In the touch screen panel, the area and/or interval of the sensing cells formed on a first region, which is capable of being bent by predetermined curvature about a folding axis is different from the area and/or interval of the sensing cells formed on a second region as a flat region except the first region.

Disclosed is a system for percutaneously steering a surgical needle. Needle steering is accomplished by taking advantage of a deflection force imparted on the bevel tip of the needle by the tissue medium as the needle is pushed through the tissue. By controlling the translation speed and rotation angle of the bevel, a flexible needle may be steered substantially without deflecting or distorting the tissue. The control inputs (translation speed and rotation angle) are computed based on a “bicycle” non-holonomic kinematic model that is a function of mechanical properties of the tissue medium. The system may be used with image-based feedback, which may provide for feedback-based refinement of the model as the needle propagates through the tissue.

Sampling is controlled to enhance analyte concentration estimation derived from noninvasive sampling. Means of assuring that the same tissue sample volume is repeatably sampled are presented, thus minimizing sampling errors due to mechanical tissue distortion, specular reflectance, and probe placement. In a first embodiment of the invention, sampling is controlled using automated delivery of a coupling fluid to a region between a tip of a sample probe and a tissue measurement site in a manner requiring minimal user interaction. In a second embodiment of the invention, sampling is controlled by controlling temperature variations, preferably with a coupling fluid, at a region about the tip of a sample probe and a sample site. In a third embodiment, sampling is procedurally controlled via timing and location of coupling fluid delivery to a sample site.

A fluid characterization sensor comprising a plurality of sensor segments is disclosed. Each segment comprises two electrodes, spaced apart so the fluid in the corresponding interval of depth for that segment is positioned between them. Complex current or impedance is measured by exciting one electrode with an AC signal, and measuring the amplitude and phase of the current in the other electrode. After automatically measuring and accounting for pre-determined gain, offset, temperature, and other parasitic influences on the raw sensor signal, the complex electrical impedance of the fluid between the electrodes is calculated from the measured phase/amplitude and/or real/imaginary components of the received electrical current signal and/or the variation of the measured response with variation in excitation frequency. Comparison of measured results with results taken using known fluids identifies fluid properties. Alternatively, measured results are compared to predicted results using forward models describing expected results for different fluids or contaminants.

Nozzles and nebulizers that can be adjusted to produce an aerosol with optimum and reproducible quality based on the feedback information obtained using laser imaging techniques are provides. Two laser-based imaging techniques based on particle image velocimetry (PIV) and optical patternation are provided to map and contrast the size and velocity distributions for indirect and direct pneumatic nebulizations in plasma spectrometry. The flow field of droplets is illuminated by two pulses from a thin laser sheet with a known time difference. The scattering of the laser light from droplets is captured by a charge coupled device (CCD), providing two instantaneous images of the particles. Pointwise cross-correlation of the corresponding images yields a two-dimensional (2-D) velocity map of the aerosol velocity field. For droplet size distribution studies, the solution is doped with a fluorescent dye and both laser induced florescence (LIF) and Mie scattering images are captured simultaneously by two CCDs with the same field of view. The ratio of the LIF/Mie images provides relative droplet size information, which is then scaled by a point calibration method via a phase Doppler particle analyzer (PDPA). Two major outcomes are realized for three nebulization systems: 1) a direct injection high efficiency nebulizer (DIHEN); 2) a large-bore DIHEN (LB-DIHEN); and 3) a PFA microflow nebulizer with a PFA Scott-type spray chamber. First, the central region of the aerosol cone from the direct injection nebulizers and the nebulizer-spray chamber arrangement comprise fast (>13 m/s and >8 m/s, respectively) and fine (<10 μm and <5 μm, respectively) droplets as compared to slow (<4 m/s) and large (>25 μm) droplets in the fringes. Second, the spray chamber acts as a momentum separator, rather than a droplet size selector, as it removes droplets having larger sizes or velocities. Smart-tunable nebulizers may utilize the measured momentum as a feedback control for adjusting certain operation properties of the nebulizer, such as operating conditions and/or critical dimensions.

A non-contact imaging apparatus for examining an object having complex surfaces or shape deformations. The imaging apparatus includes at least one imaging device for obtaining a scanned image of the exterior surfaces of the object being examined. A predetermined reference image) of an ideal model for the object is stored in a memory. An image register is coupled to the imaging device and to the memory containing the reference image of the ideal model for the object. A transformation estimator compares the scanned image to the reference image and provides a transform which maps the scanned image to the reference image and provides a set of registered object data points. One or more filter modules process the registered object data points with a priori information to reduce noise and to further enhance the accuracy and precision of the registration. A gauge estimator is coupled to the filter module. The gauge estimator utilizes the processed and registered object data to determine deformation parameters of the object, which are then displayed to an operator as gauging information.

The invention relates to noninvasive sampling. In one embodiment, the invention relates to a sample probe interface method and apparatus for targeting a tissue depth and/or pathlength that is used in conjunction with a noninvasive analyzer to control spectral variation. In a second embodiment, a signal from a sample or target probe of a tissue feature or volume is used in positioning a portion of a measuring system relative to the sample. The system is optionally used in conjunction with a targeting system used to control the sampling location of the measuring system.

An ultrasound transceiver scans a bladder in a three dimensional array to measure the thickness and surface area of the bladder to determine bladder mass. The bladder wall thickness and masses may be determined for anterior, posterior, and lateral locations of the bladder.

A system and method is provided that searches for the frequency and phase of a CDMA transmission in an iterative manner. With its automatic frequency control (AFC) disabled, the receiving system performs a coarse search for the transmitter's CDMA phase at a nominal receiving frequency. When the coarse phase is obtained, the AFC is invoked with a large-range pull-in, to obtain an initial, coarse frequency that is likely to be closer to the transmitter's frequency than the initial nominal frequency. At this coarse frequency, the receiving system repeats its search for the transmitter's CDMA phase, starting at the previously determined coarse phase. Because this second phase determination is conducted in the presence of less frequency error, it provides for a more accurate phase determination. The AFC is again invoked, but with a small-range pull-in, to obtain a finer frequency determination. Because the finer frequency determination is conducted in the presence of less phase error, a substantial improvement in the accuracy and precision of the frequency determination can be achieved. To achieve this more accurate phase and frequency determination within the same time duration as a conventional acquisition process, the initial coarse phase determination is conducted using a rapid, albeit less accurate, process than the conventional phase determination.